469 related articles for article (PubMed ID: 32909117)
1. AKT/GSK-3β/β-catenin signaling pathway participates in erythropoietin-promoted glioma proliferation.
Tang Z; Yang G; Wang X; Chen F; Liao Z; Zhang Z; Liu Z; Zeng W; Fang M; Wang W; Sun X; Huo G
J Neurooncol; 2020 Sep; 149(2):231-242. PubMed ID: 32909117
[TBL] [Abstract][Full Text] [Related]
2. FAM84B acts as a tumor promoter in human glioma via affecting the Akt/GSK-3β/β-catenin pathway.
Wang M; Li C; Shi W
Biofactors; 2021 Jul; 47(4):600-611. PubMed ID: 33759248
[TBL] [Abstract][Full Text] [Related]
3. Extracellular 5'-nucleotidase (CD73) promotes human breast cancer cells growth through AKT/GSK-3β/β-catenin/cyclinD1 signaling pathway.
Yu J; Wang X; Lu Q; Wang J; Li L; Liao X; Zhu W; Lv L; Zhi X; Yu J; Jin Y; Zou Q; Ou Z; Liu X; Zhou P
Int J Cancer; 2018 Mar; 142(5):959-967. PubMed ID: 29047106
[TBL] [Abstract][Full Text] [Related]
4. Lnc GNG12-AS1 knockdown suppresses glioma progression through the AKT/GSK-3β/β-catenin pathway.
Xiang Z; Lv Q; Chen X; Zhu X; Liu S; Li D; Peng X
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32735016
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410.
Sun WL; Kang T; Wang YY; Sun JP; Li C; Liu HJ; Yang Y; Jiao BH
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30498093
[TBL] [Abstract][Full Text] [Related]
6. Physical exercise suppresses hepatocellular carcinoma progression by alleviating hypoxia and attenuating cancer stemness through the Akt/GSK-3β/β-catenin pathway.
Xiao CL; Zhong ZP; Lü C; Guo BJ; Chen JJ; Zhao T; Yin ZF; Li B
J Integr Med; 2023 Mar; 21(2):184-193. PubMed ID: 36781361
[TBL] [Abstract][Full Text] [Related]
7. Oroxylin A reversed Fibronectin-induced glioma insensitivity to Temozolomide by suppressing IP
Ding Y; Zhou Y; Li Z; Zhang H; Yang Y; Qin H; Xu Q; Zhao L
Life Sci; 2020 Nov; 260():118411. PubMed ID: 32918978
[TBL] [Abstract][Full Text] [Related]
8. NCSTN promotes hepatocellular carcinoma cell growth and metastasis via β-catenin activation in a Notch1/AKT dependent manner.
Li H; Lan T; Xu L; Liu H; Wang J; Li J; Chen X; Huang J; Li X; Yuan K; Zeng Y; Wu H
J Exp Clin Cancer Res; 2020 Jul; 39(1):128. PubMed ID: 32631394
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of lnc-ZNF281 Inhibits the Progression of Glioma via the AKT/GSK-3
Deng YQ; Kong GY; Li S; Li F; Wen SL
J Immunol Res; 2021; 2021():5573071. PubMed ID: 34056009
[TBL] [Abstract][Full Text] [Related]
10. [Erythropoietin accelerates the proliferation of glioma cells via activating Akt pathway].
Liu ZL; Tang ZH; Huo G; Chen FL; Wang WT; Zeng WX; Chen H; Li X; Chen C
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Apr; 38(4):395-401. PubMed ID: 29735438
[TBL] [Abstract][Full Text] [Related]
11. ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway.
Yu X; Wang M; Wu J; Han Q; Zhang X
J Exp Clin Cancer Res; 2019 Jan; 38(1):40. PubMed ID: 30691485
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of DDX46 suppresses the proliferation and invasion of gastric cancer through inactivating Akt/GSK-3β/β-catenin pathway.
Chen L; Xu M; Zhong W; Hu Y; Wang G
Exp Cell Res; 2021 Feb; 399(1):112448. PubMed ID: 33347858
[TBL] [Abstract][Full Text] [Related]
13. POTEE stimulates the proliferation of pancreatic cancer by activating the PI3K/Akt/GSK-3β/β-catenin signaling.
Hao Q; Gao L; Niu W; Chen L; Zhang P; Chen Z
Biofactors; 2020 Jul; 46(4):685-692. PubMed ID: 32589786
[TBL] [Abstract][Full Text] [Related]
14. GSK-3β regulates tumor growth and angiogenesis in human glioma cells.
Zhao P; Li Q; Shi Z; Li C; Wang L; Liu X; Jiang C; Qian X; You Y; Liu N; Liu LZ; Ding L; Jiang BH
Oncotarget; 2015 Oct; 6(31):31901-15. PubMed ID: 26388612
[TBL] [Abstract][Full Text] [Related]
15. AQP8 may affect glioma proliferation and growth by regulating GSK-3β phosphorylation and nuclear transport of β-catenin.
Cai Z; Shen Z; Zhao J; Zhang H; Guo Z; Xia Q; Liang H; Liu J; Tan L; Sheng H; Zhu S
Int J Dev Neurosci; 2023 Jun; 83(4):333-345. PubMed ID: 37081713
[TBL] [Abstract][Full Text] [Related]
16. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
Xu X; Zou L; Yao Q; Zhang Y; Gan L; Tang L
Oncol Rep; 2017 Aug; 38(2):1035-1042. PubMed ID: 28627610
[TBL] [Abstract][Full Text] [Related]
17. Par6 regulates cell cycle progression through enhancement of Akt/PI3K/GSK-3β signaling pathway activation in glioma.
Liu P; Zhu C; Luo J; Lan S; Su D; Wang Q; Wei Z; Cui W; Xu C; Yang X
FASEB J; 2020 Jan; 34(1):1481-1496. PubMed ID: 31914615
[TBL] [Abstract][Full Text] [Related]
18. Vimentin loss promotes cancer proliferation through up-regulating Rictor/AKT/β-catenin signaling pathway.
Ding Y; Lv C; Zhou Y; Zhang H; Zhao L; Xu Y; Fan X
Exp Cell Res; 2021 Aug; 405(1):112666. PubMed ID: 34052237
[TBL] [Abstract][Full Text] [Related]
19. Erinacine Facilitates the Opening of the Mitochondrial Permeability Transition Pore Through the Inhibition of the PI3K/ Akt/GSK-3β Signaling Pathway in Human Hepatocellular Carcinoma.
Zhou LJ; Mo YB; Bu X; Wang JJ; Bai J; Zhang JW; Cheng AB; Ma JH; Wang YW; Xie YX
Cell Physiol Biochem; 2018; 50(3):851-867. PubMed ID: 30355923
[TBL] [Abstract][Full Text] [Related]
20. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]